Already used in Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI) for adult patients, Rapiscan is now approved for use in stress Cardiac Magnetic Resonance Imaging (CMR) Rapiscan, a pharmacological stress agent, is an alternative for patients who cannot exercise Chalfont St Giles, UK – 14 February 2022 – GE Healthcare has announced that... Read more
BOSTON – February 14, 2022 – GE (NYSE: GE) announced the appointment of Frank Jimenez as Vice President & General Counsel of GE Healthcare effective February 21, 2022. In this role, Frank will be responsible for GE Healthcare’s Global Law and Policy teams. Pete Arduini, chief executive officer of GE Healthcare, said, “Frank’s proven leadership... Read more
BOSTON – February 14, 2022 – GE (NYSE: GE) announced the appointment of Frank Jimenez as Vice President & General Counsel of GE Healthcare effective February 21, 2022. In this role, Frank will be responsible for GE Healthcare’s Global Law and Policy teams. Pete Arduini, chief executive officer of GE Healthcare, said, “Frank’s proven leadership... Read more
BOSTON – February 8, 2022 – GE (NYSE: GE) announced the appointment of Betty Larson as Chief People Officer of GE Healthcare effective March 1, 2022. Betty will be responsible for GE Healthcare’s Human Resources and Communications teams. Pete Arduini, chief executive officer of GE Healthcare, said, “Betty will be a critical partner as we... Read more
GE Healthcare enters into a comprehensive 10-year partnership with Circle Health Group, covering Circle’s national network of hospitals in the UK Partnership to empower Circle’s clinicians through cutting-edge technology and more impactful use of data Will help ensure better outcomes for NHS patients as well as Circle’s private patients London, UK – January 20 2022... Read more
Full spectrum of innovative solutions empowers better heart care and builds efficiency across the care pathway SINGAPORE — 5 Jan 2022: GE Healthcare announced a collaboration with Boston Scientific to provide a comprehensive solution offering, from diagnostic to percutaneous coronary intervention (PCI) to cardiac care centers in Southeast Asia, which also means easier access to... Read more
BOSTON – December 21, 2021 – GE (NYSE:GE) today announced that it has completed its previously announced acquisition of BK Medical, a leader in advanced surgical visualization, from Altaris Capital Partners, LLC. The companies entered into a definitive agreement for GE to purchase BK Medical for a cash purchase price of $1.45 billion on September... Read more
Partnership to jointly establish state-of the art center for molecular imaging and clinical development of targeted radionuclide therapy. Objective to accelerate precision medicine with more targeted treatment in oncology and other therapy areas. Copenhagen, Denmark – December 14, 2021 – GE Healthcare and Minerva Imaging have announced a strategic partnership with the aim to bring... Read more
Collaborations with SOPHiA GENETICS, The University of Cambridge and Optellum are intended expand access to the latest and most advanced technologies for cancer care Chicago, Nov 30 2021 — GE Healthcare announced collaborations with SOPHiA GENETICS, The University of Cambridge and Optellum as part of its vision to advance care, make precision health more accessible,... Read more
GE Healthcare introduces the industry’s first[i] computed tomography (CT) platform with built-in scalability and upgradability[ii] The new Revolution Apex platform offers the world’s fastest gantry speed: 0.23 seconds per rotation and 19.5 millisecond effective temporal resolution to freeze cardiac motion[iii] Altogether, the company’s CT platform enables healthcare facilities to keep up with the latest technology... Read more